Biomodulation with sequential intravenous IFN-alpha2b and 5-fluorouracil as second-line treatment in patients with advanced colorectal cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9726437

Download in:

View as

General Info

PMID
9726437